Microorganisms for plant pathogen inhibition
AssigneeMicrobial Discovery Group, LLC
InventorsMichael R. King, Sona Son, Amy Lange, Megan Duersteler, Elizabeth Galbraith
Life of this patent
Estimating the term…
Abstract
The invention relates to treatment of a plant with one or more microorganisms for inhibiting a plant pathogen. More particularly, the invention relates to isolated Bacillus strains, and strains having all of the identifying characteristics of these strains, and combinations thereof, for a use comprising the above-mentioned use.
Claims34
A method of treating a plant to inhibit a fungal disease or a bacterial disease, the method comprising preparing a composition comprising one or more isolated Bacillus strains wherein the composition is prepared to form a powder, a gel, a pellet, a liquid, or a freeze-dried composition, and contacting the plant with the composition wherein the one or more isolated Bacillus strains comprise an effective amount of isolated Bacillus strain 300 (NRRL No. B-50943), wherein Bacillus strain 300 (NRRL No. B-50943) inhibits the fungal disease or the bacterial disease.
A method of treating a plant to inhibit a fungal disease or a bacterial disease, the method comprising preparing a composition comprising one or more isolated Bacillus strains wherein the composition is prepared to form a powder, a gel, a pellet, a liquid, or a freeze-dried composition, and contacting the plant with the composition wherein the one or more isolated Bacillus strains comprise an effective amount of isolated Bacillus strain 1607 (NRRL No. B-67666), wherein Bacillus strain 1607 (NRRL No. B-67666) inhibits the fungal disease or the bacterial disease.
A method of treating a plant to inhibit a fungal disease or a bacterial disease, the method comprising preparing a composition comprising one or more isolated Bacillus strains wherein the composition is prepared to form a powder, a gel, a pellet, a liquid, or a freeze-dried composition, and contacting the plant with the composition wherein the one or more isolated Bacillus strains comprise an effective amount of an isolated Bacillus strain selected from the group consisting of Bacillus strain 86 (NRRL No. B-50944), Bacillus strain 300 (NRRL No. B-50943), Bacillus strain ATC2 (NRRL No. B-67134), Bacillus strain A12 (NRRL No. B-67516), Bacillus strain V17 (NRRL No. B-67664), Bacillus strain V18 (NRRL No. B-67665), Bacillus strain 1607 (NRRL No. B-67666), and combinations thereof, and inhibiting the fungal disease or the bacterial disease.
Dependencies are inferred from the claim text.